Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Taletrectinib (AB-106) is a new-generation selective inhibitor of ROS1/NTRK including ROS1,NTRK1,NTRK2 and NTRK3 with IC50 of 0.207 nM,0.622 nM,2.28 nM and 0.980 nM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 68.00 | |
2 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 161.00 | |
10 mg | In stock | $ 257.00 | |
25 mg | In stock | $ 432.00 | |
50 mg | In stock | $ 639.00 | |
100 mg | In stock | $ 891.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 196.00 |
Description | Taletrectinib (AB-106) is a new-generation selective inhibitor of ROS1/NTRK including ROS1,NTRK1,NTRK2 and NTRK3 with IC50 of 0.207 nM,0.622 nM,2.28 nM and 0.980 nM, respectively. |
Targets&IC50 | TrkA:0.622 nM, TrkB:2.28 nM, ROS1:0.207 nM, TrkC:0.980 nM |
Synonyms | DS-6051b, AB-106 |
Molecular Weight | 551.61 |
Formula | C29H34FN5O5 |
CAS No. | 1505515-69-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (81.58 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Taletrectinib 1505515-69-4 Immunology/Inflammation Tyrosine Kinase/Adaptors ROS ROS Kinase Trk receptor mutations DS-6051b AB 106 inhibit antitumor AB106 glioblastoma Inhibitor colorectal AB-106 cancer NSCLC rearrangement inhibitor